Effect of diosgenin on metabolic dysfunction: Role of ER beta in the regulation of PPAR gamma
Effect of diosgenin on metabolic dysfunction: Role of ER beta in the regulation of PPAR gamma
复制标题
薯蓣皂苷元对代谢功能障碍的影响:ERβ在PPARγ调节中的作用
DOI:
10.1016/j.taap.2015.09.015
复制
发表时间:
2015
影响因子:
3.8
通讯作者:
Hai Chunxu
中科院分区:
文献类型:
--
作者:
Wang Xin;Liu Jun;Long Zi;Sun Quangui;Liu Ying;Wang Lele;Zhang Xiaodi;Hai Chunxu
The present study was designed to investigate the effect of diosgenin (DSG) on metabolic dysfunction and to elucidate the possible molecular mechanisms. High fat (HF) diet-fed mice and 3T3-L1 preadipocytes was used to evaluate the effect of DSG. We showed that DSG attenuated metabolic dysfunction in HF diet-fed mice, as evidenced by reduction of blood glucose level and improvement of glucose and insulin intolerance. DSG ameliorated oxidative stress, reduced body weight, fat pads, and systematic lipid profiles and attenuated lipid accumulation. DSG inhibited 3T3-L1 adipocyte differentiation and reduced adipocyte size through regulating key factors. DSG inhibited PPARγ and its target gene expression both in differentiated 3T3-L1 adipocytes and fat tissues in HF diet-fed mice. Overexpression of PPARγ suppressed DSG-inhibited adipocyte differentiation. DSG significantly increased nuclear expression of ERβ. Inhibition of ERβ significantly suppressed DSG-exerted suppression of adipocyte differentiation and PPARγ expression. In response to DSG stimulation, ERβ bound with RXRα and dissociated RXRα from PPARγ, leading to the reduction of transcriptional activity of PPARγ. These data provide new insight into the mechanisms underlying the inhibitory effect of DSG on adipocyte differentiation and demonstrate that ERβ-exerted regulation of PPARγ expression and activity is critical for DSG-inhibited adipocyte differentiation.